α1,3-galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-gal antibodies

被引:65
作者
Dor, FJMF
Tseng, YL
Cheng, J
Moran, K
Sanderson, TM
Lancos, CJ
Shimizu, A
Yamada, K
Awwad, M
Sachs, D
Hawley, RJ
Schuurman, HJ
Cooper, DKC
机构
[1] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02129 USA
[2] Immerge BioTherapeut, Cambridge, MA USA
关键词
D O I
10.1097/01.TP.0000130487.68051.EB
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The expression of galactosealpha1,3galactose (Gal) in pigs has proved a barrier to xenotransplantation. Miniature swine lacking Gal (Gal(-/-) pigs) have been produced by nuclear transfer/embryo transfer. Methods. The tissues of five Gal(-/-) pigs of SLA dd haplotype (SLA(dd)) were tested for the presence of Gal epitopes by staining with the Griffonia simplicifolia IB4 lectin. Their sera were tested by flow cytometry for binding of IgM and IgG to peripheral blood mononuclear cells (PBMC) from wild-type (Gal(+/+)) SLA-matched pigs; serum cytotoxicity was also assessed. The cellular responses of PBMC from Gal(-/-) swine toward Gal(+/+) SLA-matched PBMC were tested by mixed leukocyte reaction and cell-mediated lympholysis assays. Results. None of the tissues tested showed Gal expression. Sera from all five Gal(-/-) pigs manifested IgM binding to Gal(+/+) pig PBMC, and sera from three showed IgG binding. In all five cases, cytotoxicity to Gal(+/+) cells could be demonstrated, which was lost after treatment of the sera with dithiothreitol, indicating IgM antibody-mediated cytotoxicity. PBMC from Gal(-/-) swine had no proliferative or cytolytic T-cell response toward Gal(+/+) SLA-matched PBMC. Conclusions. Gal(-/-) pigs do not express Gal epitopes and develop anti-Gal antibodies that are cytotoxic to Gal(+/+) pig cells. The absence of an in vitro cellular immune response between Gal(-/-) and Gal+/+ pigs is related to their identical SLA haplotype and indicates the absence of immunogenicity of Gal in T-cell responses. The model of Gal(+/+) organ transplantation into a Gal(-/-) SLA-matched recipient would be a valuable large animal model in the study of accommodation or B-cell tolerance.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 12 条
[1]   GENETICALLY-ENGINEERED PIGS [J].
COOPER, DKC ;
KOREN, E ;
ORIOL, R .
LANCET, 1993, 342 (8872) :682-683
[2]   Galα1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus [J].
Dor, FJMF ;
Cheng, J ;
Alt, A ;
Cooper, DKC ;
Schuurman, HJ .
XENOTRANSPLANTATION, 2004, 11 (01) :101-106
[3]   INTERACTION BETWEEN HUMAN NATURAL ANTI-ALPHA-GALACTOSYL IMMUNOGLOBULIN-G AND BACTERIA OF THE HUMAN FLORA [J].
GALILI, U ;
MANDRELL, RE ;
HAMADEH, RM ;
SHOHET, SB ;
GRIFFISS, JM .
INFECTION AND IMMUNITY, 1988, 56 (07) :1730-1737
[4]   TRANSPLANTATION IN MINIATURE SWINE .7. EVIDENCE FOR CELLULAR IMMUNE-MECHANISMS IN HYPERACUTE REJECTION OF RENAL-ALLOGRAFTS [J].
KIRKMAN, RL ;
COLVIN, RB ;
FLYE, MW ;
MELVILLEWILLIAMS, G ;
SACHS, DH .
TRANSPLANTATION, 1979, 28 (01) :24-30
[5]   Production of α-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations [J].
Kolber-Simonds, D ;
Lai, LX ;
Watt, SR ;
Denaro, M ;
Arn, S ;
Augenstein, ML ;
Betthauser, J ;
Carter, DB ;
Greenstein, JL ;
Hao, YH ;
Im, GS ;
Liu, ZH ;
Mell, GD ;
Murphy, CN ;
Park, KW ;
Rieke, A ;
Ryan, DJJ ;
Sachs, DH ;
Forsberg, EJ ;
Prather, RS ;
Hawley, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (19) :7335-7340
[6]   MECHANISM OF TOLERANCE FOLLOWING CLASS-I DISPARATE RENAL-ALLOGRAFTS IN MINIATURE SWINE - CELLULAR-RESPONSES OF TOLERANT ANIMALS [J].
KORTZ, EO ;
SAKAMOTO, K ;
SUZUKI, T ;
GUZZETTA, PC ;
CHESTER, CH ;
LUNNEY, JK ;
SACHS, DH .
TRANSPLANTATION, 1990, 49 (06) :1142-1149
[7]  
McKenzie I F, 1994, Transpl Immunol, V2, P81, DOI 10.1016/0966-3274(94)90032-9
[8]   CARBOHYDRATE ANTIGENS OF PIG-TISSUES REACTING WITH HUMAN NATURAL ANTIBODIES AS POTENTIAL TARGETS FOR HYPERACUTE VASCULAR REJECTION IN PIG-TO-MAN ORGAN XENOTRANSPLANTATION [J].
ORIOL, R ;
YE, Y ;
KOREN, E ;
COOPER, DKC .
TRANSPLANTATION, 1993, 56 (06) :1433-1442
[9]  
PESCOVITZ MD, 1985, J IMMUNOL, V134, P37
[10]  
Thall AD, 1996, TRANSPLANT P, V28, P556